Ancora Advisors, LLC Neu Base Therapeutics, Inc. Transaction History

Ancora Advisors, LLC

  • $4.06 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021
BUY
$6.92 - $12.36 $692 - $1,236
100 New
100 $1,000
Q1 2020

May 14, 2020
SELL
$4.77 - $8.23 $476 - $823
-100 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$4.5 - $8.1 $450 - $810
100 New
100 $1,000

About NeuBase Therapeutics, Inc.

NBSE Quotes by TradingView
  • Ticker NBSE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,258,700
  • Description
  • NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...
More about NBSE
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email